Table 3.
Odds ratio | 95% confidence interval | P value | |
---|---|---|---|
Glucose level | |||
<100 mg/dL | Reference | ||
100–124 mg/dL | 1.475 | [1.161, 1.876] | 0.0015 |
125–199 mg/dL | 1.655 | [1.231, 2.225] | 0.0009 |
200+ mg/dL | 2.530 | [1.632, 3.922] | <0.0001 |
Serum insulin > 17 µU/mL | 1.900 | [1.532, 2.357] | <0.0001 |
Triglyceride level | |||
<125 mg/dL | Reference | ||
125–199 mg/dL | 1.415 | [1.126, 1.778] | 0.0029 |
200+ mg/dL | 1.448 | [1.117, 1.877] | 0.0052 |
ALT level | |||
Quartile 1 (<20 U/L) | Reference | ||
Quartile 2: (20–25 U/L) | 1.690 | [1.247, 2.290] | 0.0007 |
Quartile 3: (26–36 U/L) | 2.765 | [2.065, 3.703] | <0.0001 |
Quartile 4: (37+ U/L) | 5.144 | [3.616, 7.319] | <0.0001 |
AST level | |||
Quartile 1, 2, or 3 (<31 U/L) | Reference | ||
Quartile 4 (31+ U/L) | 1.696 | [1.288, 2.235] | 0.0002 |
BUN level | |||
Quartile 1 (<13 mg/dL) | 1.556 | [1.264, 1.917] | <0.0001 |
Quartile 2, 3, or 4 (13+ mg/dL) | Reference | ||
Use of metformin | 1.432 | [1.175, 1.745] | 0.0004 |
Use of fibric acid derivative | 1.766 | [1.188, 2.626] | 0.0050 |
Use of tricyclics or modified cyclics | 1.488 | [1.099, 2.013] | 0.0101 |
Female gender | 1.295 | [1.017, 1.649] | 0.0359 |
Pre-op weight change | |||
Weight gain | 3.325 | [2.288, 4.834] | <0.0001 |
0–4 %EWL | 2.636 | [1.793, 3.876] | <0.0001 |
5–9 %EWL | 2.436 | [1.703, 3.484] | <0.0001 |
10–19 %EWL | 1.561 | [1.115, 2.185] | 0.0094 |
20+ %EWL | Reference |
c-statistic = 0.772.